154 related articles for article (PubMed ID: 12153991)
1. AT1 receptor blockade increases cardiac bradykinin via neutral endopeptidase after induction of myocardial infarction in rats.
Walther T; Siems WE; Hauke D; Spillmann F; Dendorfer A; Krause W; Schultheiss HP; Tschöpe C
FASEB J; 2002 Aug; 16(10):1237-41. PubMed ID: 12153991
[TBL] [Abstract][Full Text] [Related]
2. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
[TBL] [Abstract][Full Text] [Related]
3. Bradykinin metabolism in rat hearts with left-ventricular hypertrophy following myocardial infarction.
Dumoulin MJ; Adam A; Rouleau JL; Gosselin H; Lamontagne D
Can J Physiol Pharmacol; 2003 Jul; 81(7):740-6. PubMed ID: 12897822
[TBL] [Abstract][Full Text] [Related]
4. Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
Hara K; Kobayashi N; Watanabe S; Tsubokou Y; Matsuoka H
Am J Hypertens; 2001 Apr; 14(4 Pt 1):321-30. PubMed ID: 11336177
[TBL] [Abstract][Full Text] [Related]
5. Bradykinin metabolism in the postinfarcted rat heart: role of ACE and neutral endopeptidase 24.11.
Raut R; Rouleau JL; Blais C; Gosselin H; Molinaro G; Sirois MG; Lepage Y; Crine P; Adam A
Am J Physiol; 1999 May; 276(5):H1769-79. PubMed ID: 10330262
[TBL] [Abstract][Full Text] [Related]
6. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
Duncan AM; James GM; Anastasopoulos F; Kladis A; Briscoe TA; Campbell DJ
J Pharmacol Exp Ther; 1999 Apr; 289(1):295-303. PubMed ID: 10087017
[TBL] [Abstract][Full Text] [Related]
7. The bradykinin B1 receptor contributes to the cardioprotective effects of AT1 blockade after experimental myocardial infarction.
Tschöpe C; Spillmann F; Altmann C; Koch M; Westermann D; Dhayat N; Dhayat S; Bascands JL; Gera L; Hoffmann S; Schultheiss HP; Walther T
Cardiovasc Res; 2004 Feb; 61(3):559-69. PubMed ID: 14962486
[TBL] [Abstract][Full Text] [Related]
8. Effects of the vasopeptidase inhibitor omapatrilat on cardiac endogenous kinins in rats with acute myocardial infarction.
Blais C; Lapointe N; Rouleau JL; Clément R; Gervais N; Geadah D; Adam A
Peptides; 2001 Jun; 22(6):953-62. PubMed ID: 11390026
[TBL] [Abstract][Full Text] [Related]
9. Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats.
Benetos A; Levy BI; Lacolley P; Taillard F; Duriez M; Safar ME
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3196-201. PubMed ID: 9409311
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin-converting enzyme inhibition in infarct-induced heart failure in rats: bradykinin versus angiotensin II.
Stauss HM; Zhu YC; Redlich T; Adamiak D; Mott A; Kregel KC; Unger T
J Cardiovasc Risk; 1994 Oct; 1(3):255-62. PubMed ID: 7621306
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat.
Wollert KC; Studer R; Doerfer K; Schieffer E; Holubarsch C; Just H; Drexler H
Circulation; 1997 Apr; 95(7):1910-7. PubMed ID: 9107180
[TBL] [Abstract][Full Text] [Related]
12. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.
Liu YH; Yang XP; Sharov VG; Nass O; Sabbah HN; Peterson E; Carretero OA
J Clin Invest; 1997 Apr; 99(8):1926-35. PubMed ID: 9109437
[TBL] [Abstract][Full Text] [Related]
13. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
Campbell DJ; Anastasopoulos F; Duncan AM; James GM; Kladis A; Briscoe TA
J Pharmacol Exp Ther; 1998 Nov; 287(2):567-77. PubMed ID: 9808682
[TBL] [Abstract][Full Text] [Related]
14. Chronic effects of ACE-inhibition (quinapril) and angiotensin-II-type-1 receptor blockade (losartan) on atrial natriuretic peptide in brain nuclei of rats with experimental myocardial infarction.
Hu K; Bahner U; Gaudron P; Palkovits M; Ring M; Fehle A; Kruse B; Ertl G
Basic Res Cardiol; 2001; 96(3):258-66. PubMed ID: 11403419
[TBL] [Abstract][Full Text] [Related]
15. Preservation of left ventricular mechanical function and energy metabolism in rats after myocardial infarction by the angiotensin-converting enzyme inhibitor quinapril.
Horn M; Neubauer S; Frantz S; Hugel S; Hu K; Gaudron P; Schnackerz K; Ertl G
J Cardiovasc Pharmacol; 1996 Feb; 27(2):201-10. PubMed ID: 8720418
[TBL] [Abstract][Full Text] [Related]
16. Effects of differential blockade of the renin-angiotensin system in postinfarcted rats.
Lacour C; Roccon A; Galindo G; Canals F; Hogie M; Segondy D; Briand D; Roque C; Herbert JM; Nisato D
Fundam Clin Pharmacol; 2004 Jun; 18(3):299-307. PubMed ID: 15147281
[TBL] [Abstract][Full Text] [Related]
17. Comparison between chronic converting enzyme inhibition and AT1 blockade in mRen2 transgenic rats.
Lantelme P; Lo M; Mullins JJ; Gharib C; Bizollon CA; Sassard J
J Cardiovasc Pharmacol; 1996 Apr; 27(4):476-81. PubMed ID: 8847862
[TBL] [Abstract][Full Text] [Related]
18. Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.
Fraccarollo D; Galuppo P; Schmidt I; Ertl G; Bauersachs J
Cardiovasc Res; 2005 Jul; 67(1):97-105. PubMed ID: 15949473
[TBL] [Abstract][Full Text] [Related]
19. Kallidin- and bradykinin-degrading pathways in human heart: degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase.
Kokkonen JO; Kuoppala A; Saarinen J; Lindstedt KA; Kovanen PT
Circulation; 1999 Apr; 99(15):1984-90. PubMed ID: 10209002
[TBL] [Abstract][Full Text] [Related]
20. Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive rats.
Roksnoer LC; van Veghel R; de Vries R; Garrelds IM; Bhaggoe UM; Friesema EC; Leijten FP; Poglitsch M; Domenig O; Clahsen-van Groningen MC; Hoorn EJ; Jan Danser AH; Batenburg WW
Kidney Int; 2015 Jul; 88(1):109-20. PubMed ID: 25830765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
